Admission respiratory status predicts mortality in COVID‐19

COVID‐19 has significant case fatality. Glucocorticoids are the only treatment shown to improve survival, but only among patients requiring supplemental oxygen. WHO advises patients to seek medical care for “trouble breathing,” but hypoxemic patients frequently have no respiratory symptoms. Our coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Neal A., Jensen, Paul N., Harris, Andrew W., Nguyen, Daniel D., Huang, Henry D., Cheng, Richard K., Savla, Jainy J., Larsen, Timothy R., Gomez, Joanne Michelle D., Du‐Fay‐de‐Lavallaz, Jeanne M., Lemaitre, Rozenn N., McKnight, Barbara, Gharib, Sina A., Sotoodehnia, Nona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242415/
https://www.ncbi.nlm.nih.gov/pubmed/34028169
http://dx.doi.org/10.1111/irv.12869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242415/
https://www.ncbi.nlm.nih.gov/pubmed/34028169
http://dx.doi.org/10.1111/irv.12869

Ejemplares similares